The primary end point for the study was reduction in diastolic blood pressure (DBP); the relationship was found "not significant. There were two secondary end points: 1) reduction in systolic blood pressure (SBP) which was reduced from 127.7 mmHg to 127.1 mmHg after 36 months of the intervention; and 2) reduced incidence of hypertension which was "not significant." Thus, TOHP II found that hypertension risk reduction by reducing dietary sodium was not significant ( RR=.88 (N.S.) at 18 months and 36 months.
